Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain medicine
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
10h
on MSN
FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
14h
on MSN
Brand-new painkiller approved by US health agency
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
AFP
21h
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Small plane crashes in Philly
Black boxes recovered
Receives $250K settlement
Boy, 5, dies in explosion
Drone pilot to plead guilty
Apologizes for old tweets
Cause of death revealed
New York doctor indicted
Tour boat captain sentenced
WBD hit with copyright suit
To again run for Senate?
Walgreens suspends dividend
Activists call for boycott
Ends abortion travel policy
Todd exits NBC News
Opens probe into NPR, PBS
Granted legal personhood
IL won’t hire Jan. 6 rioters
Seeking a new trial
Cancerous tumor removed
Gold hits all-time high
'As Tears Go By' singer dies
FDA approves painkiller
Olympic gold medalist dies
Confirmed interior secretary
Ground stop amid IT outage
Partners w/ US national labs
In talks to reincorporate?
Top leaders asked to resign
To raise hourly pay
US inflation ticked higher
Recuses self from Act 10 suit
Inmate's transfer blocked
Michigan priest loses license
Feedback